Estimating expression of Micro RNAs, p-16, MSI, and PDL-1 molecular markers in cervical cancer patients
Not Applicable
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2024/06/068989
- Lead Sponsor
- Institutional Intramural Funds Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Biopsy proven squamous cell cancer of Cervix uteri.
2) Patients with age more than 18 years or less than 80 years.
3) ECOG (0,1,2)
4) Patients amenable for curative intent treatment.
5) Suitable for Brachytherapy boost.
6) Have given their consent for the study.
7) FIGO Stage II,III
Exclusion Criteria
1) Patients with distant metastasis
2) Previous history of abdominal or pelvic radiotherapy / partial or total hysterectomy / neoadjuvant chemotherapy
4) Severe medical condition impairing complete treatment delivery
5) Immunocompromised states and psychological illness
6) Patients planned only either for EBRT, or Brachytherapy
7) Pregnant and lactating women
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method